SURESH RAMALINGAM was named deputy director of the Winship Cancer Institute of Emory University. He will also serve as assistant dean for cancer research at the Emory School of Medicine. Ramalingam will lead the integration of the research, clinical, and educational components within Winship. This position was previously held by Fadlo Khuri, who assumed the... […]
H. BENJAMIN HARVEY, of Massachusetts General Hospital, and COURTNEY MORENO, of Emory University, received the 2016 Bruce J. Hillman Fellowship in Scholarly Publishing from the American College of Radiology.
The Mayo Clinic in Jacksonville, Fla. will collaborate with Morphotek Inc., a subsidiary of Eisai Inc., in a clinical study in patients with folate receptor alpha positive, triple-negative breast cancer.
FDA issued a complete response letter to a Biologics License Application submitted by Telesta Therapeutics Inc. for MCNA. FDA said that additional phase III clinical trial for MCNA would be necessary to adequately establish MCNA's efficacy and safety.
Venetoclax received its third Breakthrough Therapy Designation from the FDA, for a combination treatment with hypomethylating agents for patients with untreated acute myeloid leukemia who are ineligible to receive standard induction therapy.
M. BEATRIZ CURRIER joined the executive leadership of Miami Cancer Institute at Baptist Health South Florida as director of Cancer Patient Support Services.
KEITH HANSON MCGREGOR was named CEO of the European Society for Medical Oncology.
STAND UP TO CANCER CANADA announced a four-year cancer stem cell dream team focused on brain cancer in children and adults.
THE VAN ANDEL RESEARCH INSTITUTE-Stand Up To Cancer Epigenetics Dream Team's first clinical trial moved forward, targeting metastatic colorectal cancer.
SAGAR LONIAL was named chair of the Department of Hematology and Medical Oncology at Emory University School of Medicine and Winship Cancer Institute.
